ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 152 filers reported holding ARCUS BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 3.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,563 | -100.0% | 142,800 | -48.2% | 0.00% | -55.6% |
| Q2 2021 | $7,571,000 | +4.9% | 275,700 | +7.3% | 0.01% | 0.0% |
| Q1 2021 | $7,214,000 | +98.8% | 256,900 | -1.7% | 0.01% | +125.0% |
| Q1 2020 | $3,628,000 | +65.4% | 261,416 | +20.3% | 0.00% | +100.0% |
| Q4 2019 | $2,194,000 | +71.1% | 217,238 | +54.2% | 0.00% | +100.0% |
| Q3 2019 | $1,282,000 | +366.2% | 140,838 | +307.0% | 0.00% | – |
| Q2 2019 | $275,000 | – | 34,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |